Michael G. Kauffman
2016
In 2016, Michael G. Kauffman earned a total compensation of $1.5M as Chief Executive Officer at Karyopharm Therapeutics, a 66% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $247,200 |
|---|---|
| Option Awards | $758,523 |
| Salary | $515,000 |
| Other | $11,260 |
| Total | $1,531,983 |
Kauffman received $758.5K in option awards, accounting for 50% of the total pay in 2016.
Kauffman also received $247.2K in non-equity incentive plan, $515K in salary and $11.3K in other compensation.
Rankings
In 2016, Michael G. Kauffman's compensation ranked 6,151st out of 14,075 executives tracked by ExecPay. In other words, Kauffman earned more than 56.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,151 out of 14,075 | 56th |
Division Manufacturing | 2,253 out of 5,486 | 59th |
Major group Chemicals And Allied Products | 741 out of 1,900 | 61st |
Industry group Drugs | 561 out of 1,543 | 64th |
Industry Pharmaceutical Preparations | 440 out of 1,173 | 63rd |
Source: SEC filing on April 28, 2017.
Kauffman's colleagues
We found three more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2016.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019